Trial Profile
Differences between Mitiglinide/Voglibose Fixed-dose Combination and Glimepiride in Modifying Low-density Lipoprotein Heterogeneity in Japanese Type-2 Diabetic Patients: A Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Mar 2017
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Mitiglinide/voglibose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Mar 2017 New trial record